Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP261715.RAW4IzU0IqxoezOYvFIf-38VxK7CZK3WdpOz8wjKPkMa4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP261715.RAW4IzU0IqxoezOYvFIf-38VxK7CZK3WdpOz8wjKPkMa4130_assertion type Assertion NP261715.RAW4IzU0IqxoezOYvFIf-38VxK7CZK3WdpOz8wjKPkMa4130_head.
- NP261715.RAW4IzU0IqxoezOYvFIf-38VxK7CZK3WdpOz8wjKPkMa4130_assertion wasGeneratedBy ECO_0000203 NP261715.RAW4IzU0IqxoezOYvFIf-38VxK7CZK3WdpOz8wjKPkMa4130_provenance.
- NP261715.RAW4IzU0IqxoezOYvFIf-38VxK7CZK3WdpOz8wjKPkMa4130_assertion wasDerivedFrom befree-20150227 NP261715.RAW4IzU0IqxoezOYvFIf-38VxK7CZK3WdpOz8wjKPkMa4130_provenance.
- NP261715.RAW4IzU0IqxoezOYvFIf-38VxK7CZK3WdpOz8wjKPkMa4130_assertion SIO_000772 12794243 NP261715.RAW4IzU0IqxoezOYvFIf-38VxK7CZK3WdpOz8wjKPkMa4130_provenance.
- NP261715.RAW4IzU0IqxoezOYvFIf-38VxK7CZK3WdpOz8wjKPkMa4130_assertion evidence source_evidence_literature NP261715.RAW4IzU0IqxoezOYvFIf-38VxK7CZK3WdpOz8wjKPkMa4130_provenance.
- NP261715.RAW4IzU0IqxoezOYvFIf-38VxK7CZK3WdpOz8wjKPkMa4130_assertion description "[Twenty-two lesions from 17 patients with IPMT, including 12 benign (IPMT Adenoma) and 10 malignant (IPMT Carcinoma In Situ [CIS] (n = 4) and Invasive IPMT (n = 6) lesions, were immunostained for Survivin, p53, Bcl-2 and Ki-67.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP261715.RAW4IzU0IqxoezOYvFIf-38VxK7CZK3WdpOz8wjKPkMa4130_provenance.